Results 91 to 100 of about 2,011 (166)

Polyamine metabolism in cancer: drivers of immune evasion, ferroptosis and therapy resistance. [PDF]

Expert Rev Mol Med
Chenna SS, Gajula SNR, Nalla LV.
europepmc   +1 more source

Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l‑Eflornithine

ACS Omega, 2020
Mikael Boberg, Anna C. Jonson, Hanna Leek, Rasmus Jansson-Löfmark, Michael Ashton   +4 more
doaj   +1 more source

Editorial: Women in CNS drug delivery: 2022-2024. [PDF]

Front Drug Deliv
Veszelka S, Burek M, Thomas SA.
europepmc   +1 more source

Advancing neuroblastoma care: future horizons after approval of eflornithine by FDA. [PDF]

Int J Surg
Nazir A, Nazir A, Kandel K.
europepmc   +1 more source

Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy. [PDF]

Dermatol Ther (Heidelb)
Davis M, Smith S, Skaggs B, Gradwohl K, Griffin J, Mauskar MM.   +5 more
europepmc   +1 more source

Protein arginine methyltransferases in protozoan parasites: a new path for antiparasitic chemotherapy? [PDF]

Microb Cell
Campagnaro GD, Pomel S.
europepmc   +1 more source

Iwilfin (eflornithine) approved by the FDA as the first and only oral maintenance therapy for high-risk neuroblastoma in adult and pediatric patients: Narrative review. [PDF]

Medicine (Baltimore)
Shakeel A, Baloch A, Kumari V, Kazmi SKZ, Aftab K, Abid S, Syed A, Syed A, Yousuf J, Hasanain M, Anjum MU, Anjum MU, Mahmmoud Fadelallah Eljack M.   +12 more
europepmc   +1 more source

Effects of Cash Transfer and Incentive Programs on Service Utilization and Treatment Outcomes Related to Neglected Tropical Diseases and Their Impact on Health and Nutrition in Low- and Middle-Income Countries: Protocol for a Systematic Review. [PDF]

JMIR Res Protoc
Hasan SMT, Dayal R, Nishan AA, Ghatak S, Chakraborty P, Maitra S, Raisa ST, Khan N, Mondal D, Ahmed T, Hazra A.   +10 more
europepmc   +1 more source

Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US. [PDF]

Front Med (Lausanne)
Reggiardo G, Natale A, Santoro N, Giannuzzi V, Pansieri C, Felisi M, Bonifazi D, Ceci A.   +7 more
europepmc   +1 more source

Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas. [PDF]

Brief Bioinform
Kishk A, Pires Pacheco M, Heurtaux T, Sauter T.   +3 more
europepmc   +1 more source